Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

References

• Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell 2011; 146:682-95; PMID:21884931; http://dx.doi.org/10.1016/j.cell.2011.07.030
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 2015; 47:e147; PMID:25766616; http://dx.doi.org/10.1038/emm.2014.117
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21; PMID:11099404; http://dx.doi.org/10.1126/science.290.5497.1717
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, et al. TFEB links autophagy to lysosomal biogenesis. Science 2011; 332:1429-33; PMID:21617040; http://dx.doi.org/10.1126/science.1204592
   PubMed Web of Science ®Google Scholar
• Seok S, Fu T, Choi SE, Li Y, Zhu R, Kumar S, Sun X, Yoon G, Kang Y, Zhong W, et al. Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 2014; 516:108-11; PMID:25383523
   PubMed Web of Science ®Google Scholar
• Warr MR, Binnewies M, Flach J, Reynaud D, Garg T, Malhotra R, Debnath J, Passegué E. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013; 494:323-7; PMID:23389440; http://dx.doi.org/10.1038/nature11895
   PubMed Web of Science ®Google Scholar
• Perera RM, Stoykova S, Nicolay BN, Ross KN, Fitamant J, Boukhali M, Lengrand J, Deshpande V, Selig MK, Ferrone CR, et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 2015; 524:361-5; PMID:26168401; http://dx.doi.org/10.1038/nature14587
   PubMed Web of Science ®Google Scholar
• Chauhan S, Goodwin JG, Chauhan S, Manyam G, Wang J, Kamat AM, Boyd DD. ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell 2013; 50:16-28; PMID:23434374; http://dx.doi.org/10.1016/j.molcel.2013.01.024
   PubMed Web of Science ®Google Scholar
• Bowman CJ, Ayer DE, Dynlacht BD. Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. Nat Cell Biol 2014; 16:1202-14; PMID:25402684; http://dx.doi.org/10.1038/ncb3062
   PubMed Web of Science ®Google Scholar
• Lapierre LR, Kumsta C, Sandri M, Ballabio A, Hansen M. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy 2015; 11:867-80; PMID:25836756; http://dx.doi.org/10.1080/15548627.2015.1034410
   PubMed Web of Science ®Google Scholar
• Milan G, Romanello V, Pescatore F, Armani A, Paik JH, Frasson L, Seydel A, Zhao J, Abraham R, Goldberg AL, et al. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 2015; 6:6670; PMID:25858807; http://dx.doi.org/10.1038/ncomms7670
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 2014; 39:199-218; PMID:24647116; http://dx.doi.org/10.1016/j.tibs.2014.02.002
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yamamoto M. FRBM Special issue “Nrf2 regulated Redox Signaling and Metabolism in Physiology and Medicine” Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med 2015
   Web of Science ®Google Scholar
• Jiang T, Harder B, Vega MR, Wong PK, Chapman E, Zhang DD. p62 links autophagy and Nrf2 signaling. Free Radic Biol Med 2015; 88(Pt B):199-204
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 2013; 51:618-31; PMID:24011591; http://dx.doi.org/10.1016/j.molcel.2013.08.003
   PubMed Web of Science ®Google Scholar
• Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, Johansen T. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 2010; 285:22576-91; PMID:20452972; http://dx.doi.org/10.1074/jbc.M110.118976
   PubMed Web of Science ®Google Scholar
• Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun 2014; 5:3496; PMID:24667209
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-9; PMID:16625204; http://dx.doi.org/10.1038/nature04724
   PubMed Web of Science ®Google Scholar
• Inoue K, Rispoli J, Kaphzan H, Klann E, Chen EI, Kim J, Komatsu M, Abeliovich A. Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway. Mol Neurodegener 2012; 7:48; PMID:22998728; http://dx.doi.org/10.1186/1750-1326-7-48
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441:880-4; PMID:16625205; http://dx.doi.org/10.1038/nature04723
   PubMed Web of Science ®Google Scholar
• Jaworski T, Dewachter I, Seymour CM, Borghgraef P, Devijver H, Kugler S, Van Leuven F. Alzheimer's disease: old problem, new views from transgenic and viral models. Biochimica et biophysica acta 2010; 1802:808-18; PMID:20332023; http://dx.doi.org/10.1016/j.bbadis.2010.03.005
   PubMed Web of Science ®Google Scholar
• Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 2007; 120:4081-91; PMID:18032783; http://dx.doi.org/10.1242/jcs.019265
   PubMed Web of Science ®Google Scholar
• Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci 2008; 28:6926-37; PMID:18596167; http://dx.doi.org/10.1523/JNEUROSCI.0800-08.2008
   PubMed Web of Science ®Google Scholar
• http://www.webcitation.org/query?url=https%3A%2F%2Fgenome.ucsc.edu%2F&date=2015-07-29
   Google Scholar
• http://www.webcitation.org/query?url=http%3A%2F%2Fjaspar.genereg.net%2F&date=2015-07-29
   Google Scholar
• McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003; 278:21592-600; PMID:12682069; http://dx.doi.org/10.1074/jbc.M300931200
   PubMed Web of Science ®Google Scholar
• Potteti HR, Reddy NM, Hei TK, Kalvakolanu DV, Reddy SP. The NRF2 activation and antioxidative response are not impaired overall during hyperoxia-induced lung epithelial cell death. Oxid Med Cell Longev 2013; 2013:798401; PMID:23738042; http://dx.doi.org/10.1155/2013/798401
   PubMed Web of Science ®Google Scholar
• Hac A, Domachowska A, Narajczyk M, Cyske K, Pawlik A, Herman-Antosiewicz A. S6K1 controls autophagosome maturation in autophagy induced by sulforaphane or serum deprivation. Euro J Cell Biol 2015; 94(10):470-81; PMID:26054233
   PubMed Web of Science ®Google Scholar
• Lee JH, Jeong JK, Park SY. Sulforaphane-induced autophagy flux prevents prion protein-mediated neurotoxicity through AMPK pathway. Neuroscience 2014; 278:31-9; PMID:25130556; http://dx.doi.org/10.1016/j.neuroscience.2014.07.072
   PubMed Web of Science ®Google Scholar
• Jo C, Kim S, Cho SJ, Choi KJ, Yun SM, Koh YH, Johnson GV, Park SI. Sulforaphane induces autophagy through ERK activation in neuronal cells. FEBS Lett 2014; 588:3081-8; PMID:24952354; http://dx.doi.org/10.1016/j.febslet.2014.06.036
   PubMed Web of Science ®Google Scholar
• Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 2008; 172:786-98; PMID:18258852; http://dx.doi.org/10.2353/ajpath.2008.070904
   PubMed Web of Science ®Google Scholar
• Joshi G, Gan KA, Johnson DA, Johnson JA. Increased Alzheimer's disease-like pathology in the APP/ PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging 2015; 36:664-79; PMID:25316599; http://dx.doi.org/10.1016/j.neurobiolaging.2014.09.004
   PubMed Web of Science ®Google Scholar
• Kraft AD, Lee JM, Johnson DA, Kan YW, Johnson JA. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem 2006; 98:1852-65; PMID:16945104; http://dx.doi.org/10.1111/j.1471-4159.2006.04019.x
   PubMed Web of Science ®Google Scholar
• Dodson M, Redmann M, Rajasekaran NS, Darley-Usmar V, Zhang J. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem J 2015; 469:347-55; PMID:26205490; http://dx.doi.org/10.1042/BJ20150568
   PubMed Web of Science ®Google Scholar
• Settembre C, Ballabio A. TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes. Autophagy 2011; 7:1379-81; PMID:21785263; http://dx.doi.org/10.4161/auto.7.11.17166
   PubMed Web of Science ®Google Scholar
• Fullgrabe J, Klionsky DJ, Joseph B. Histone post-translational modifications regulate autophagy flux and outcome. Autophagy 2013; 9:1621-3; PMID:23934085; http://dx.doi.org/10.4161/auto.25803
   PubMed Web of Science ®Google Scholar
• Lau A, Tian W, Whitman SA, Zhang DD. The predicted molecular weight of Nrf2: it is what it is not. Antioxid Redox Signal 2013; 18:91-3; PMID:22703241; http://dx.doi.org/10.1089/ars.2012.4754
   PubMed Web of Science ®Google Scholar
• Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 1995; 15:4184-93; PMID:7623813; http://dx.doi.org/10.1128/MCB.15.8.4184
   PubMed Web of Science ®Google Scholar
• Igarashi K, Hoshino H, Muto A, Suwabe N, Nishikawa S, Nakauchi H, Yamamoto M. Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex. J Biol Chem 1998; 273:11783-90; PMID:9565602; http://dx.doi.org/10.1074/jbc.273.19.11783
   PubMed Web of Science ®Google Scholar
• Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006; 38:769-89; PMID:17145701; http://dx.doi.org/10.1080/03602530600971974
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004; 24:10941-53; PMID:15572695; http://dx.doi.org/10.1128/MCB.24.24.10941-10953.2004
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Dis 2012; 11:709-30; PMID:22935804; http://dx.doi.org/10.1038/nrd3802
   PubMed Web of Science ®Google Scholar
• Nilsson P, Loganathan K, Sekiguchi M, Matsuba Y, Hui K, Tsubuki S, Tanaka M, Iwata N, Saito T, Saido TC. Abeta secretion and plaque formation depend on autophagy. Cell Rep 2013; 5:61-9; PMID:24095740; http://dx.doi.org/10.1016/j.celrep.2013.08.042
   PubMed Web of Science ®Google Scholar
• Agholme L, Hallbeck M, Benedikz E, Marcusson J, Kagedal K. Amyloid-beta secretion, generation, and lysosomal sequestration in response to proteasome inhibition: involvement of autophagy. J Alzheimer's Dis 2012; 31:343-58; PMID:22555375
   PubMed Web of Science ®Google Scholar
• Son SM, Song H, Byun J, Park KS, Jang HC, Park YJ, Mook-Jung I. Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy 2012; 8:1842-4; PMID:22931791; http://dx.doi.org/10.4161/auto.21861
   PubMed Web of Science ®Google Scholar
• Zheng L, Terman A, Hallbeck M, Dehvari N, Cowburn RF, Benedikz E, Kågedal K, Cedazo-Minguez A, Marcusson J. Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 2011; 7:1528-45; PMID:22108004; http://dx.doi.org/10.4161/auto.7.12.18051
   PubMed Web of Science ®Google Scholar
• Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, et al. Macroautophagy–a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 2005; 171:87-98; PMID:16203860; http://dx.doi.org/10.1083/jcb.200505082
   PubMed Web of Science ®Google Scholar
• Yu WH, Kumar A, Peterhoff C, Shapiro Kulnane L, Uchiyama Y, Lamb BT, Cuervo AM, Nixon RA. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int J Biochem Cell Biol 2004; 36:2531-40; PMID:15325590; http://dx.doi.org/10.1016/j.biocel.2004.05.010
   PubMed Web of Science ®Google Scholar
• Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, Callahan JW, Mahuran DJ. Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 2003; 278:26687-94; PMID:12736250; http://dx.doi.org/10.1074/jbc.M304009200
   PubMed Web of Science ®Google Scholar
• Nilsson P, Sekiguchi M, Akagi T, Izumi S, Komori T, Hui K, Sörgjerd K, Tanaka M, Saito T, Iwata N, et al. Autophagy-related protein 7 deficiency in amyloid beta (Abeta) precursor protein transgenic mice decreases Abeta in the multivesicular bodies and induces Abeta accumulation in the Golgi. Am J Pathol 2015; 185:305-13; PMID:25433221; http://dx.doi.org/10.1016/j.ajpath.2014.10.011
   PubMed Web of Science ®Google Scholar
• Wang Y, Mandelkow E. Degradation of tau protein by autophagy and proteasomal pathways. Biochemical Society transactions 2012; 40:644-52; PMID:22817709; http://dx.doi.org/10.1042/BST20120071
   PubMed Web of Science ®Google Scholar
• Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, Oddo S. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging cell 2013; 12:370-80; PMID:23425014; http://dx.doi.org/10.1111/acel.12057
   PubMed Web of Science ®Google Scholar
• Liu Y, Su Y, Wang J, Sun S, Wang T, Qiao X, Run X, Li H, Liang Z. Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase. Neurochem Int 2013; 62:458-67; PMID:23357480; http://dx.doi.org/10.1016/j.neuint.2013.01.014
   PubMed Web of Science ®Google Scholar
• Ozcelik S, Fraser G, Castets P, Schaeffer V, Skachokova Z, Breu K, Clavaguera F, Sinnreich M, Kappos L, Goedert M, et al. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PloS one 2013; 8:e62459; PMID:23667480; http://dx.doi.org/10.1371/journal.pone.0062459
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B, Stefanis L, Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005; 1:11-22; PMID:16874045; http://dx.doi.org/10.4161/auto.1.1.1513
   PubMed Web of Science ®Google Scholar
• Martinez-Vicente M. Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation. Semin Cell Dev Biol 2015; 40:115-26; PMID:25843774; http://dx.doi.org/10.1016/j.semcdb.2015.03.005
   PubMed Web of Science ®Google Scholar
• Wong YC, Holzbaur EL. Autophagosome dynamics in neurodegeneration at a glance. J Cell Sci 2015; 128:1259-67; PMID:25829512; http://dx.doi.org/10.1242/jcs.161216
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 2015; 85:40-7; PMID:26062630; http://dx.doi.org/10.1212/WNL.0000000000001702
   PubMed Web of Science ®Google Scholar
• Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 2007; 66:75-85; PMID:17204939; http://dx.doi.org/10.1097/nen.0b013e31802d6da9
   PubMed Web of Science ®Google Scholar
• Raina AK, Templeton DJ, Deak JC, Perry G, Smith MA. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep 1999; 4:23-7; PMID:10714272; http://dx.doi.org/10.1179/135100099101534701
   PubMed Web of Science ®Google Scholar
• Wang Y, Santa-Cruz K, DeCarli C, Johnson JA. NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. Neurobiol Aging 2000; 21:525-31; PMID:10924765; http://dx.doi.org/10.1016/S0197-4580(00)00114-7
   PubMed Web of Science ®Google Scholar
• Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 2006; 27:252-61; PMID:16399210; http://dx.doi.org/10.1016/j.neurobiolaging.2005.01.016
   PubMed Web of Science ®Google Scholar
• Tanji K, Miki Y, Ozaki T, Maruyama A, Yoshida H, Mimura J, Matsumiya T, Mori F, Imaizumi T, Itoh K, et al. Phosphorylation of serine 349 of p62 in Alzheimer's disease brain. Acta neuropathologica communications 2014; 2:50; PMID:24886973; http://dx.doi.org/10.1186/2051-5960-2-50
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Reyes AE, Chacon MA, Cerpa W, Villalon A, Montiel J, Merabachvili G, Aldunate R, Bozinovic F, Aboitiz F. Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu. Neurobiol Aging 2005; 26:1023-8; PMID:15748782; http://dx.doi.org/10.1016/j.neurobiolaging.2004.09.016
   PubMed Web of Science ®Google Scholar
• von Otter M, Landgren S, Nilsson S, Zetterberg M, Celojevic D, Bergstrom P, Minthon L, Bogdanovic N, Andreasen N, Gustafson DR, et al. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mechanisms Ageing Dev 2010; 131:105-10; PMID:20064547; http://dx.doi.org/10.1016/j.mad.2009.12.007
   PubMed Web of Science ®Google Scholar
• von Otter M, Bergstrom P, Quattrone A, De Marco EV, Annesi G, Soderkvist P, Wettinger SB, Drozdzik M, Bialecka M, Nissbrandt H, et al. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study. BMC Med Genet 2014; 15:131; PMID:25496089; http://dx.doi.org/10.1186/s12881-014-0131-4
   PubMed Web of Science ®Google Scholar
• Bergstrom P, von Otter M, Nilsson S, Nilsson AC, Nilsson M, Andersen PM, Hammarsten O, Zetterberg H. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15:130-7; PMID:24102512; http://dx.doi.org/10.3109/21678421.2013.839708
   PubMed Web of Science ®Google Scholar
• Gan L, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci 2012; 32:17775-87; PMID:23223297; http://dx.doi.org/10.1523/JNEUROSCI.3049-12.2012
   PubMed Web of Science ®Google Scholar
• Lastres Becker I, Garcia-Yague AJ, Scannevin RH, Casarejos MJ, Kugler S, Rabano A, et al. Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease. Antioxid Redox Signal 2016; 25(2):61-77
   PubMed Web of Science ®Google Scholar
• Bott LC, Badders NM, Chen KL, Harmison GG, Bautista E, Shih CC, Katsuno M, Sobue G, Taylor JP, Dantuma NP, et al. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet 2016; PMID:26962150; http://dx.doi.org/10.1093/hmg/ddw073
   PubMed Web of Science ®Google Scholar
• Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, Van Leuven F. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 2005; 280:3963-73; PMID:15509565; http://dx.doi.org/10.1074/jbc.M409876200
   PubMed Web of Science ®Google Scholar
• Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999; 274:6483-92; PMID:10037741; http://dx.doi.org/10.1074/jbc.274.10.6483
   PubMed Web of Science ®Google Scholar
• Lastres-Becker I, Innamorato NG, Jaworski T, Rabano A, Kugler S, Van Leuven F, Cuadrado A. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain 2014; 137:78-91; PMID:24277722; http://dx.doi.org/10.1093/brain/awt323
   PubMed Web of Science ®Google Scholar
• Rojo AI, Medina-Campos ON, Rada P, Zuniga-Toala A, Lopez-Gazcon A, Espada S, Pedraza-Chaverri J, Cuadrado A. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. Free Radic Biol Med 2012; 52:473-87; PMID:22142471; http://dx.doi.org/10.1016/j.freeradbiomed.2011.11.003
   PubMed Web of Science ®Google Scholar
• Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 2010; 58:588-98; PMID:19908287; http://dx.doi.org/10.1002/glia.20947
   PubMed Web of Science ®Google Scholar